POM — POMDOCTOR Income Statement
0.000.00%
Last trade - 00:00- $17.83m
- $85.62m
- CNY399.91m
Annual income statement for POMDOCTOR, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 215 | 245 | 305 | 343 | 400 |
| Cost of Revenue | |||||
| Gross Profit | 52.5 | 54.9 | 38.7 | 47.7 | 52.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 295 | 249 | 327 | 368 | 519 |
| Operating Profit | -79.7 | -3.59 | -22.2 | -25.8 | -119 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -96.2 | -19.8 | -36.9 | -37.4 | -131 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -96.2 | -19.8 | -36.9 | -37.4 | -131 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -96.2 | -19.8 | -37 | -37.4 | -131 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -188 | -126 | -145 | -143 | -213 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -8.28 | -6.36 | -7.28 | -7.15 | -21.8 |